EntryPoint Capital, LLC

Position in HRMY — Harmony Biosciences Holdings, Inc.

CIK 1992519 NEW YORK, NY

Position in HRMY

as of Mar 31, 2026 · filed May 14, 2026 Compact

Position Value

$679,634

+$392,024 QoQ

Shares Held

24,264

+215.7% QoQ

Ownership

0.042%

of shares outstanding

% of Portfolio

0.20%

of 13F equity value

Holder Rank

—

not a current holder

Holding Since

Dec 2023

9 quarters on record

Voting authority Sole 100.ToString("F0")% Shared 0.ToString("F0")% None 0.ToString("F0")%

Healthcare · as of Mar 31, 2026

EntryPoint Capital, LLC holds $19,484,871 across 56 Biotechnology names. HRMY ranks #5 (3.5% of the industry book) .

#	Ticker	Company	Shares	Value (USD)
1	TBPH	Theravance Biopharma, Inc.	49,739	$807,263
2	LGND	Ligand Pharmaceuticals Inc	3,922	$783,027
3	ADMA	Adma Biologics, Inc.	83,961	$756,488
4	VCEL	Vericel Corp	22,674	$729,422
5	HRMY	Harmony Biosciences Holdings, Inc. This page	24,264	$679,634
6	UPB	Upstream Bio, Inc.	73,568	$662,112
7	INCY	Incyte Corp	6,483	$610,179
8	RARE	Ultragenyx Pharmaceutical Inc.	26,119	$547,193

9 filing rows on record

Report Date	Value (USD)	Shares	Change	Type	Discretion	Filed
2026-03-31	$679,634	24,264	+215.7%	Shares	Sole	2026-05-14
2025-12-31	$287,610	7,686	+1.4%	Shares	Sole	2026-02-12
2025-09-30	$208,877	7,579	-38.4%	Shares	Sole	2025-11-13
2025-06-30	$388,553	12,296	-3.7%	Shares	Sole	2025-08-11
2025-03-31	$423,836	12,770	-60.2%	Shares	Sole	2025-05-14
2024-12-31	$1,104,010	32,084	+651.2%	Shares	Sole	2025-02-11
2024-06-30	$128,856	4,271	+9.3%	Shares	Sole	2024-08-13
2024-03-31	$131,230	3,908	-19.4%	Shares	Sole	2024-05-14
2023-12-31	$156,622	4,849	—	Shares	Sole	2024-02-14
No filing history on record for this holder in this stock.